Cooper Companies | COO - Ebit

Aktienkurs
70.00
Täglich Wechseln
-0.71 -1.00%
Monatlich
-15.60%
Jährlich
-14.33%
Q1 Prognose
67.81




Ebit Veränderung Datum
Abbott USD 2.54B 358M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
AtriCure USD 2.49M 2.28M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Bausch Health Companies USD 719M 2M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Bayer EUR 1.11B 1.51B 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Dentsply International USD 538M 26M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Globus Medical USD 181.31M 298.83M 2025-12
Haemonetics USD 67.4M 13.71M 2025-12
Hologic USD 240.9M 12.1M 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
J&J USD 5.11B 2.3B 2025-12
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Novartis USD 4.06B 413M 2025-12
ResMed USD 497.6M 35.25M 2025-12
STAAR Surgical USD -10.93M 35.38M 2025-12
Steris USD 278M 7.1M 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 76.31M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12